CELLDEX THERAPEUTICS INC (CLDX) — insider trading
Health Care · NASDAQ
CELLDEX THERAPEUTICS INC (CLDX) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-06-25).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | Jain Rita | Director | Grant / award / vesting (derivative) | 26,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Torres Denice | Director | Grant / award / vesting (derivative) | 26,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Marucci Anthony S | Director, Officer (PRESIDENT & CEO) | Grant / award / vesting (derivative) | 375,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | KELER TIBOR | Officer (EXECUTIVE VP & CSO) | Grant / award / vesting (derivative) | 115,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | PEPIN RONALD | Officer (SR. VP & CBO) | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Crowley Elizabeth | Officer (SR. VP & CPDO) | Grant / award / vesting (derivative) | 100,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Cavanaugh Sarah | Officer (SVP OF CORP AFFAIRS & ADMIN.) | Grant / award / vesting (derivative) | 95,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Martin Samuel Bates | Officer (SVP AND CFO) | Grant / award / vesting (derivative) | 93,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Heath-Chiozzi Margo | Officer (SVP OF REGULATORY AFFAIRS) | Grant / award / vesting (derivative) | 95,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Young Diane C. | Officer (SVP, CHIEF MEDICAL OFFICER) | Grant / award / vesting (derivative) | 57,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Jimenez Freddy A. | Officer (SVP & GENERAL COUNSEL) | Grant / award / vesting (derivative) | 93,000 | $0.00 | $0 | Form 4 |
| 2026-06-25 | Lawver Teri L | Officer (SVP & Chief Commercial Officer) | Grant / award / vesting (derivative) | 90,000 | $0.00 | $0 | Form 4 |
Ask the chat about CLDX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CELLDEX THERAPEUTICS INC (CLDX).
Last updated 2026-06-25 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.